Investors
 

NASDAQ: TTPH

$ 10.64

0.14 (1.33%)

Day High: 10.70
Day Low:  10.18
Volume:    138,800

4:00 PM ET
Aug 1, 2014



Delayed at least 20 min., by eSignal.


Stock price graph

     

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Jul 28, 2014
Tetraphase Pharmaceuticals Completes Enrollment of IGNITE 1 Eravacycline Phase 3 Clinical Trial in Complicated Intra-abdominal Infections

Jul 23, 2014
Tetraphase Pharmaceuticals to Present at Upcoming Conferences

View all »Events & Presentations

Aug 6, 2014
InvestMNt 2014

Sep 3, 2014
Baird 2014 Health Care Conference